Pharma Welcomes UK Incentive Plan To Tackle AMR

 
• By Kevin Grogan

There has been an enthusiastic response from industry to the news that NICE and NHS England are to explore a new payment model that pays pharmaceutical companies based on how valuable their medicines are to the country's health service, rather than on the quantity of antibiotics sold.

PillsGBP
UK to pursue new payment model for antibiotics • Source: Shutterstock

More from Anti-infective

More from Therapy Areas